Scientific Opinion on Lead in Food EFSA Panel on Contaminants in the Food Chain (CONTAM)

被引:284
作者
Alexander, Jan [1 ]
Benford, Diane [1 ]
Boobis, Alan [1 ]
Ceccatelli, Sandra [1 ]
Cravedi, Jean-Pierre [1 ]
Di Domenico, Alessandro [1 ]
Doerge, Daniel [1 ]
Dogliotti, Eugenia [1 ]
Edler, Lutz [1 ]
Fanner, Peter [1 ]
Filipic, Metka [1 ]
Fink-Gremmels, Johanna [1 ]
Fuerst, Peter [1 ]
Guerin, Thierry [1 ]
Knutsen, Helle Katrine [1 ]
Machala, Miroslav [1 ]
Mutti, Antonio [1 ]
Schlatter, Josef [1 ]
van Leeuwen, Rolaf [1 ]
机构
[1] European Food Safety Author, Parma, Italy
关键词
lead; occurrence; dietary exposure; food consumption; risk assessment; adults; children; margin of exposure;
D O I
10.2903/j.efsa.2010.1570
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Lead occurs primarily in the inorganic form in the environment. Human exposure is mainly via food and water, with some via air, dust and soil. In average adult consumers, lead dietary exposure ranges from 0.36 to 1.24, up to 2.43 mu g/kg body weight (b.w.) per day in high consumers in Europe. Exposure of infants ranges from 0.21 to 0.94 mu g/kg b.w. per day and in children from 0.80 to 3.10 (average consumers), up to 5.51 (high consumers) mu g/kg b.w. per day. Cereal products contribute most to dietary lead exposure, while dust and soil can be important non-dietary sources in children. Lead is absorbed more in children than in adults and accumulates in soft tissues and, over time, in bones. Half-lives of lead in blood and bone are approximately 30 days and 10-30 years, respectively, and excretion is primarily in urine and faeces. The Panel on Contaminants in the Food Chain (CONTAM Panel) identified developmental neurotoxicity in young children and cardiovascular effects and nephrotoxicity in adults as the critical effects for the risk assessment. The respective BMDLs derived from blood lead levels in mu g/L (corresponding dietary intake values in mu g/kg b.w. per day) were: developmental neurotoxicity BMDL01, 12 (0.50); effects on systolic blood pressure BMDL01, 36 (1.50); effects on prevalence of chronic kidney disease BMDL10, 15 (0.63). The CONTAM Panel concluded that the current PTWI of 25 mu g/kg b.w. is no longer appropriate as there is no evidence for a threshold for critical lead-induced effects. In adults, children and infants the margins of exposures were such that the possibility of an effect from lead in some consumers, particularly in children from 1-7 years of age, cannot be excluded. Protection of children against the potential risk of neurodevelopmental effects would be protective for all other adverse effects of lead, in all populations.
引用
收藏
页数:151
相关论文
共 395 条
[11]   DELTA-AMINOLEVULINIC-ACID DEHYDRATASE ISOZYMES AND LEAD TOXICITY [J].
ASTRIN, KH ;
BISHOP, DF ;
WETMUR, JG ;
KAUL, B ;
DAVIDOW, B ;
DESNICK, RJ .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 514 :23-29
[12]  
AUFDERHEIDE AC, 1992, NEUROTOXICOLOGY, V13, P809
[13]   THE EFFECT OF DOSE ON THE DISPOSITION OF LEAD IN RATS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION [J].
AUNGST, BJ ;
DOLCE, JA ;
FUNG, HL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1981, 61 (01) :48-57
[14]   Isotopic characterisation of lead in contaminated soils from the vicinity of a non-ferrous metal smelter near Plovdiv, Bulgaria [J].
Bacon, JR ;
Dinev, NS .
ENVIRONMENTAL POLLUTION, 2005, 134 (02) :247-255
[15]   Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells [J].
Bannon, DI ;
Abounader, R ;
Lees, PSJ ;
Bressler, JP .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (01) :C44-C50
[16]   Iron status influences trace element levels in human [J].
Bárány, E ;
Bergdahl, IA ;
Bratteby, LE ;
Lundh, T ;
Samuelson, G ;
Skerfving, S ;
Oskarsson, A .
ENVIRONMENTAL RESEARCH, 2005, 98 (02) :215-223
[17]   Guidance of the Scientific Committee on a request from EFSA related to Uncertainties in Dietary Exposure Assessment Request No EFSA-Q-2004-019 Adopted on 14 December 2006 [J].
Barlow, Sue ;
Chesson, Andrew ;
Collins, John ;
Dybing, Erik ;
Flynn, Albert ;
Fruijtier-Polloth, Claudia ;
Hardy, Tony ;
Knaap, Ada ;
Kuiper, Harry ;
Le Neindre, Pierre ;
Schans, Jan ;
Schlatter, Josef ;
Silano, Vittorio ;
Skerving, Steffan ;
Vannier, Philippe .
EFSA JOURNAL, 2007, 5 (01)
[18]   Use of the benchmark dose approach in risk assessment Guidance of the Scientific Committee [J].
Barlow, Susan ;
Chesson, Andrew ;
Collins, John D. ;
Flynn, Albert ;
Hardy, Anthony ;
Jany, Klaus-Dieter ;
Knaap, Ada ;
Kuiper, Harry ;
Larsen, John-Christian ;
Lovell, David ;
Le Neindre, Pierre ;
Schans, Jan ;
Schlatter, Josef ;
Silano, Vittorio ;
Skerfving, Staffan ;
Vannier, Philippe .
EFSA JOURNAL, 2009, 7 (06)
[19]  
BARRY PSI, 1975, BRIT J IND MED, V32, P119
[20]  
BARTON JC, 1978, J LAB CLIN MED, V92, P536